Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells

[1]  J. J. Li,et al.  Hormonal Carcinogenesis , 2020, Springer New York.

[2]  M. Miglino,et al.  Canine amniotic membrane mesenchymal stromal/stem cells: Isolation, characterization and differentiation. , 2019, Tissue & cell.

[3]  W. Woodward,et al.  In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines , 2018, Veterinary and comparative oncology.

[4]  H. Abrahamse,et al.  Phthalocyanine induced phototherapy coupled with Doxorubicin; a promising novel treatment for breast cancer , 2017, Expert review of anticancer therapy.

[5]  K. Storbeck,et al.  Steroid metabolism in breast cancer: Where are we and what are we missing? , 2017, Molecular and Cellular Endocrinology.

[6]  M. Cecchini,et al.  Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease , 2016, Scientific Reports.

[7]  T. Rosol,et al.  Triple-negative breast cancer: is there a treatment on the horizon? , 2016, Oncotarget.

[8]  Bernd W. Brandt,et al.  Corrigendum: Intrinsic challenges in ancient microbiome reconstruction using 16S rRNA gene amplification , 2016, Scientific Reports.

[9]  Martin H. Schaefer,et al.  Cell type-specific properties and environment shape tissue specificity of cancer genes , 2016, Scientific Reports.

[10]  W. Woodward,et al.  Steroid hormone secretion in inflammatory breast cancer cell lines , 2015, Hormone molecular biology and clinical investigation.

[11]  S. Inoue,et al.  Estrogen-Related Receptors in Breast Cancer and Prostate Cancer , 2015, Front. Endocrinol..

[12]  T. Huang,et al.  Acoustic separation of circulating tumor cells , 2015, Proceedings of the National Academy of Sciences.

[13]  W. Woodward,et al.  Establishment and Characterization of a New Cell Line of Canine Inflammatory Mammary Cancer: IPC-366 , 2015, PloS one.

[14]  P. Papageorgis.  TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis , 2015, Journal of oncology.

[15]  H. Sasano,et al.  The intracrinology of breast cancer , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  R. Zeillinger,et al.  The Sulfatase Pathway for Estrogen Formation: Targets for the Treatment and Diagnosis of Hormone-Associated Tumors , 2013, Journal of drug delivery.

[17]  E. Meiyanto,et al.  Synergistic effects of ethyl acetate fraction of Ficus septica Burm. f. and doxorubicin chemotherapy on T47D human breast cancer cell line. , 2012, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[18]  K. Kang,et al.  Isolation and Characterization of Canine Amniotic Membrane-Derived Multipotent Stem Cells , 2012, PloS one.

[19]  O. Parolini,et al.  Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest , 2012, Journal of cellular and molecular medicine.

[20]  M. Miglino,et al.  Placental tissues as sources of stem cells—Review , 2012 .

[21]  J. Carroll,et al.  Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? , 2012, Molecular endocrinology.

[22]  T. Soboleva,et al.  Multilevel regulation of steroid synthesis and metabolism in the bovine placenta , 2012, Molecular reproduction and development.

[23]  C. Catacchio,et al.  Isolation, proliferation, cytogenetic, and molecular characterization and in vitro differentiation potency of canine stem cells from foetal adnexa: A comparative study of amniotic fluid, amnion, and umbilical cord matrix , 2011, Molecular reproduction and development.

[24]  J. Manson,et al.  Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. , 2011, Journal of the National Cancer Institute.

[25]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[26]  A. Quiñones‐Hinojosa,et al.  Mesenchymal stem cells: new approaches for the treatment of neurological diseases. , 2010, Current stem cell research & therapy.

[27]  J. Butany,et al.  Drug-related cardiac pathology , 2009, Journal of Clinical Pathology.

[28]  L. Marconato,et al.  Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008). , 2009, Journal of the American Veterinary Medical Association.

[29]  L. Buscail,et al.  Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo , 2009, PloS one.

[30]  R. Auchus,et al.  Androgens, estrogens, and hydroxysteroid dehydrogenases , 2009, Molecular and Cellular Endocrinology.

[31]  G. Suh,et al.  Inflammatory Mammary Carcinoma in a Dog , 2008 .

[32]  Narine Sarvazyan,et al.  Anthracycline cardiotoxicity: from bench to bedside. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Toshio Miki,et al.  Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells , 2008, Stem cells.

[34]  O. Parolini,et al.  Human Amnion Mesenchyme Harbors Cells with Allogeneic T‐Cell Suppression and Stimulation Capabilities , 2008, Stem cells.

[35]  M. van Griensven,et al.  Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. , 2007, Tissue engineering.

[36]  Zhiyong Guo,et al.  Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole. , 2006, Cancer research.

[37]  F. Schmitt,et al.  c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[38]  G. D. Cassali,et al.  Carcinogênese hormonal e neoplasias hormônio-dependentes , 2004 .

[39]  M. Lehmann,et al.  Doxorubicin and two of its analogues are preferential inducers of homologous recombination compared with mutational events in somatic cells of Drosophila melanogaster. , 2003, Mutation research.

[40]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[41]  Shiyou Zhou,et al.  The effects of amniotic membrane on polymorphonuclear cells. , 2003, Chinese medical journal.

[42]  L. Peña,et al.  Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  N. Chobanyan.  Re: Henderson,B.E. and Feigelson,H.S. (2000) hormonal carcinogenesis. Carcinogenesis, 21, 427-433. , 2001, Carcinogenesis.

[44]  R. Hawkins.  How best to express oestrogen receptor activity. , 2000, European journal of cancer.

[45]  R. Cooper,et al.  Atrazine disrupts the hypothalamic control of pituitary-ovarian function. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[47]  W. Murphy,et al.  Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone–‐releasing hormone effect). Distinction from poor tumor differentiation , 1994, Cancer.

[48]  M. Schemper,et al.  Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. , 1990, Cancer research.

[49]  C. Alves,et al.  Quimioterapia antineoplásica em cães e gatos uma revisão das opções de tratamento por via oral , 2013 .

[50]  Raj Kumar,et al.  Steroid hormone receptors in cancer development: a target for cancer therapeutics. , 2011, Cancer letters.

[51]  John E. Hall,et al.  Tratado De Fisiologia Medica , 2011 .

[52]  J. Graham,et al.  PPARγ1 and LXRα face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 , 2010, Nuclear Receptor Signaling.

[53]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[54]  L. Moe.  Population-based incidence of mammary tumours in some dog breeds. , 2001, Journal of reproduction and fertility. Supplement.

[55]  B. Henderson,et al.  Hormonal carcinogenesis. , 2000, Carcinogenesis.

[56]  S. Thorpe.  Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance. , 1988, Acta oncologica.

[57]  C. Bowers,et al.  Hormonal therapy in cancer of the breast. XIV. The effect of 19‐nortestosterone propionate therapy on clinical course and hormonal excretion , 1959, Cancer.